EMEA-001115-PIP01-10-M06

Key facts

Invented name
Adasuve
Active substance
loxapine
Therapeutic area
Psychiatry
Decision number
P/0295/2018
PIP number
EMEA-001115-PIP01-10-M06
Pharmaceutical form(s)
  • Inhalation powder
  • pre-dispensed
Condition(s) / indication(s)
  • Treatment of bipolar disorder
  • Treatment of schizophrenia
Route(s) of administration
Inhalation use
Contact for public enquiries
Ferrer Internacional S.A.
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating